Navigation Links
Mission Pharmacal Conducts Online Survey of Osteoporosis Patients
Date:1/15/2014

SAN ANTONIO, Jan. 15, 2014 /PRNewswire/ -- Most osteoporosis patients want a choice in the medication they take, according to a recent online survey* sponsored by Mission Pharmacal Company. The survey, conducted by Inspire among the National Osteoporosis Foundation online support community, revealed that 74 percent of osteoporosis patients surveyed prefer to take medication that comes in a form other than a pill or a tablet.

(Photo: http://photos.prnewswire.com/prnh/20140115/PH47087)

Mission Pharmacal sponsored the online survey to raise awareness of osteoporosis and to encourage people to talk to their doctors about treatment options. "The results of this survey show that patients are interested in options," says Robert Recker, MD, MACP, FACE, Director, Osteoporosis Research Center, Creighton University, Omaha, Neb. "We take medication compliance very seriously because we know it can result in fewer fractures with osteoporosis."

BINOSTO® (alendronate sodium) Effervescent Tablet for oral solution (70 mg) from Mission Pharmacal delivers an easy-to-take, strawberry-flavored alternative to pills for individuals with osteoporosis who either can't or prefer not to swallow pills. It is the first and only effervescent tablet that can be dissolved in water to create a buffered solution for the treatment of osteoporosis.

Studies show that bisphosphonate treatments, such as BINOSTO, can reduce the risk of fractures with osteoporosis up to 50 percent. "At the end of the day, drugs don't work if patients don't take them," adds Jim Self, General Manager of Bone Health at Mission Pharmacal. "When we launched BINOSTO, we knew that many osteoporosis patients had difficulty swallowing pills or tablets. What we learned from this survey is that even patients who can tolerate pills still want an alternative, such as a buffered solution like BINOSTO."

According to the National Osteoporosis Foundation, 9 million people in the United States have osteoporosis and another 43 percent have low bone density. Without treatment, their bones weaken and become fragile, making them more likely to break. Ultimately, one in two women and one in four men with osteoporosis will break a bone after the age of 50.

Alendronate sodium provides fracture-risk reduction at the hip and spine and increases bone density. Until recently, it was available only in pill form. BINOSTO is formulated with the same 70 mg of alendronate sodium as other standard alendronate weekly therapies, yet it is delivered in a tablet that dissolves in water.

"Broken bones, especially in older adults, can lead to disability and even death," says Recker. "Between 20 and 25 percent of people with hip fractures will die within a year of the fracture. Of those who survive, nearly half will require help with activities of daily living.

"Many people make lifestyle changes to reduce their risk of cancer and heart disease, yet they
don't realize that osteoporosis is a common and potentially fatal disease," says Recker. "If having treatment options improves compliance, we can help more people treat osteoporosis."

Find the complete survey results at binosto.com

* Mission surveyed members of the Inspire/National Osteoporosis Foundation Support Community, a peer-to-peer support group, in June and July 2013. A total of 331 women participated in the survey; 291 of them had been diagnosed with osteoporosis.

About BINOSTO

About Mission Pharmacal Company


'/>"/>
SOURCE Mission Pharmacal Company
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CVS Caremark Research Finds Optimal Adherence to Medications Prescribed Post-Heart Attack Reduces Hospital Readmissions
2. BioLineRx Announces Regulatory Submission for Novel Stem Cell Mobilization Treatment
3. When Prescribing New Drugs for Crohns Disease or Ulcerative Colitis, Surveyed EU5 Gastroenterologists Will Prioritize Remission Rates Over Cost and Reimbursement Hurdles
4. CareCentrixs HomeSTAR Program Reduces Hospital Readmissions Nearly 20 Percent Among Aetna Members
5. Elton John AIDS Foundation and Mylan Give $1 Million to Nigeria for the Elimination of Mother-to-Child Transmission of HIV
6. SynteractHCR Supports the San Diego Rescue Mission for Second Year in a Row
7. Mammoth Medical Missions Is Among the First to Provide Medical Assistance After Typhoon Haiyan Devastates the Philippines
8. Star Scientific Announces Leadership Transition, Acceleration of Plans for Submission of an IND to FDA for Pharmaceutical Version of Anatabine Compound
9. IGI Laboratories, Inc. Announces Thirteenth ANDA Submission
10. goBalto, Inc. expands Tracker 2.0s analytics and submissions features
11. The Joint Commission Issues Sentinel Event Alert on Preventing Retained Foreign Objects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... 23, 2016 Gamida Cell, a ... of cancer and orphan genetic diseases, announced today it ... million from the Israel Innovation Authority (formerly the Office ... Economy and Industry. The mission of the Israel Innovation ... industries, including science and technology, while stimulating economic growth. ...
(Date:5/22/2016)... 2016 DS Biopharma (DS) ... anti-inflammatory compound DS102 in chronic obstructive pulmonary disease ... (NASH) patients. Recent DS preclinical data ... tissue and has bronchodilatory, anti-inflammatory and anti-fibrotic properties ... Company will publish further detail on these findings ...
(Date:5/20/2016)... 2016 - Revenue Forecasts ... Growth Hormones, Recombinant Coagulation Factors and Regenerative Medicine ... New Study Reveals Selling Opportunities and Revenue Prospects ... ,What is the future of biologics, especially new ... commercial analysis. Staying ahead in data and knowledge, ...
Breaking Medicine Technology:
(Date:5/23/2016)... (PRWEB) , ... May 23, 2016 , ... Researchers can ... so routine. A fresh look at this technique may yield big benefits. Scientists ... reproducibility of experiments in a cell culture laboratory—and lessen the risk of contamination ...
(Date:5/23/2016)... ... May 23, 2016 , ... In light of ... reminds pet owners that intervening at the first sign of their pet overheating ... normal body mechanisms cannot keep the body’s temperature within a safe range. Considered ...
(Date:5/23/2016)... ... May 23, 2016 , ... The Society for Women’s Health ... to move on from that role. , “No one in Washington led the way ... said SWHR Founder Florence Haseltine, MD, PhD. “We offer our deep gratitude to Phyllis ...
(Date:5/23/2016)... ... 2016 , ... Hadley Institute for the Blind and Visually ... or visually impaired, announces the election of Julie S. Tye as its next ... of Trustees retained Morris & Berger, a firm specializing in non-profit executive searches, ...
(Date:5/23/2016)... NY (PRWEB) , ... May 23, 2016 , ... ... the company’s top management team to meet the needs of its recent and ... to drive continued growth and business development across widening market segments. Max joined ...
Breaking Medicine News(10 mins):